Bank of America’s Immunomedics Inc IMMU Stock Holding History

Bank of America’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100,000	Closed	-$1.43M	–	7570
2018 Q4	$1.43M	Hold	100,000	–	–	﹤0.01%	4126
2018 Q3	$2.08M	Hold	100,000	–	–	﹤0.01%	3952
2018 Q2	$2.37M	Hold	100,000	–	–	﹤0.01%	3843
2018 Q1	$1.46M	Buy	+100,000	New	+$1.63M	﹤0.01%	4112
2017 Q1	–	Sell	-11,500	Closed	-$42K	–	7376
2016 Q4	$42K	Buy	+11,500	New	+$34K	﹤0.01%	6011
2014 Q4	–	Sell	-1,100	Closed	-$4K	–	8096
2014 Q3	$4K	Buy	+1,100	New	+$3.72K	﹤0.01%	7634
2014 Q2	–	Sell	-800	Closed	-$3K	–	8302
2014 Q1	$3K	Hold	800	–	–	﹤0.01%	7489
2013 Q4	$4K	Buy	+800	New	+$3.56K	﹤0.01%	7541

Bank of America's IMMU Position: Q4 2020 in Review

Bank of America sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,076,061 shares — an estimated $91.5M sold.

Bank of America first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $91.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Bank of America reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Bank of America sold 1,076,061 Immunomedics Inc shares in Q4 2020, an estimated $91.5M.
Bank of America first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
Bank of America's Immunomedics Inc position peaked at $91.5M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.